<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.thecerbatgem.com/2019/11/24/zacks-analysts-anticipate-guardant-health-inc-nasdaqgh-to-post-0-30-eps.html"/>
    <meta property="og:site_name" content="The Cerbat Gem"/>
    <meta property="article:published_time" content="2019-11-24T12:12:49+00:00"/>
    <meta property="og:title" content="Zacks: Analysts Anticipate Guardant Health Inc (NASDAQ:GH) to Post -$0.30 EPS"/>
    <meta property="og:description" content="Equities analysts expect that Guardant Health Inc (NASDAQ:GH) will report earnings per share of ($0.30) for the current quarter, Zacks reports. Three analysts have made estimates for Guardant Health’s earnings. The highest EPS estimate is ($0.28) and the lowest is ($0.34). Guardant Health also posted earnings of ($0.30) per share during the same quarter last […]"/>
  </head>
  <body>
    <article>
      <h1>Zacks: Analysts Anticipate Guardant Health Inc (NASDAQ:GH) to Post -$0.30 EPS</h1>
      <address><time datetime="2019-11-24T12:12:49+00:00">24 Nov 2019, 12:12</time> by <a rel="author" href="https://www.thecerbatgem.com/author/teresa" target="_blank">Teresa Graham</a></address>
      <figure>
        <img src="https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&amp;zc=1&amp;src=https://www.marketbeat.com/logos/generic-stocks.jpg"/>
      </figure>
      <p>Equities analysts expect that Guardant Health Inc (NASDAQ:GH) will report earnings per share of ($0.30) for the current quarter, <a href="https://www.americanconsumernews.net/scripts/click.aspx?Zacks=1">Zacks</a> reports. Three analysts have made estimates for Guardant Health’s earnings. The highest EPS estimate is ($0.28) and the lowest is ($0.34). Guardant Health also posted earnings of ($0.30) per share during the same quarter last year. The firm is expected to report its next quarterly earnings results on Tuesday, March 10th.</p>
      <p>According to Zacks, analysts expect that Guardant Health will report full year earnings of ($0.88) per share for the current financial year, with EPS estimates ranging from ($0.96) to ($0.84). For the next year, analysts anticipate that the firm will report earnings of ($1.18) per share, with EPS estimates ranging from ($1.55) to ($0.67). Zacks’ earnings per share averages are an average based on a survey of sell-side research analysts that cover Guardant Health.</p>
      <p>Guardant Health (NASDAQ:GH) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.14) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.39) by $0.25. Guardant Health had a negative net margin of 40.99% and a negative return on equity of 11.70%. The business had revenue of $60.85 million during the quarter, compared to the consensus estimate of $45.40 million. During the same quarter in the prior year, the firm posted ($1.94) earnings per share. The company’s revenue was up 180.4% compared to the same quarter last year.</p>
      <p>A number of research analysts have recently commented on the stock. <a href="https://www.americanconsumernews.net/scripts/click.aspx?ValuEngine=1&amp;Symbol=GH">ValuEngine</a> raised shares of Guardant Health from a “hold” rating to a “buy” rating in a research report on Friday, November 1st. Cowen set a $110.00 target price on Guardant Health and gave the stock a “buy” rating in a research report on Wednesday, August 7th. William Blair restated an “outperform” rating on shares of Guardant Health in a research report on Friday, November 8th. JPMorgan Chase &amp; Co. boosted their target price on Guardant Health from $90.00 to $135.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Finally, Canaccord Genuity restated a “buy” rating and set a $125.00 price objective on shares of Guardant Health in a research report on Friday, November 8th. Six investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $107.60.</p>
      <p>Shares of <a href="https://www.marketbeat.com/stocks/NASDAQ/GH/earnings/">GH</a> traded down $0.79 during midday trading on Tuesday, reaching $78.04. The stock had a trading volume of 598,400 shares, compared to its average volume of 1,129,760. Guardant Health has a 1-year low of $32.33 and a 1-year high of $112.21. The company’s fifty day simple moving average is $69.15 and its two-hundred day simple moving average is $81.01. The company has a market cap of $7.40 billion and a price-to-earnings ratio of -27.87.</p>
      <p>In related news, Director Ian T. Clark sold 538 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $94.05, for a total transaction of $50,598.90. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through <a href="https://www.sec.gov/Archives/edgar/data/1336504/000162828019011256/wf-form4_156702876964626.xml">this hyperlink</a>. Also, major shareholder Vision Fund (Aiv M1) Softbank sold 4,900,000 shares of Guardant Health stock in a transaction dated Wednesday, September 11th. The stock was sold at an average price of $77.00, for a total value of $377,300,000.00. In the last quarter, insiders have sold 5,008,772 shares of company stock worth $385,670,569. Company insiders own 13.00% of the company’s stock.</p>
      <p>A number of hedge funds and other institutional investors have recently added to or reduced their stakes in GH. Griffin Asset Management Inc. boosted its holdings in shares of Guardant Health by 1.4% in the second quarter. Griffin Asset Management Inc. now owns 11,336 shares of the company’s stock valued at $979,000 after acquiring an additional 154 shares in the last quarter. Great West Life Assurance Co. Can lifted its stake in Guardant Health by 6.8% during the third quarter. Great West Life Assurance Co. Can now owns 2,562 shares of the company’s stock valued at $164,000 after buying an additional 163 shares in the last quarter. NEXT Financial Group Inc increased its holdings in Guardant Health by 20.0% in the second quarter. NEXT Financial Group Inc now owns 1,200 shares of the company’s stock worth $104,000 after buying an additional 200 shares during the last quarter. SeaCrest Wealth Management LLC grew its stake in shares of Guardant Health by 2.3% in the third quarter. SeaCrest Wealth Management LLC now owns 9,892 shares of the company’s stock worth $631,000 after acquiring an additional 220 shares during the last quarter. Finally, First Trust Advisors LP lifted its holdings in shares of Guardant Health by 0.4% during the first quarter. First Trust Advisors LP now owns 71,871 shares of the company’s stock valued at $5,513,000 after acquiring an additional 264 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.</p>
      <p>
        <b>About Guardant Health</b>
      </p>
      <p>Guardant Health, Inc, a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications.</p>
      <p>See Also: <a href="https://www.marketbeat.com/financial-terms/what-is-diluted-earnings-per-share/">What is diluted earnings per share (Diluted EPS)?</a></p>
      <p>
        <a href="https://www.zacks.com/registration/pfp/?ALERT=ZER_LINK&amp;ADID=AMERBMN_CONTENT_ZER&amp;skip_rpt_name_check=skip_rpt_name_check&amp;t=GH">Get a free copy of the Zacks research report on Guardant Health (GH)</a>
      </p>
      <p>For more information about research offerings from Zacks Investment Research, visit <a href="https://www.americanconsumernews.net/scripts/click.aspx?Zacks=1">Zacks.com</a></p>
      <figure>
        <img src="https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx?Prefix=NASDAQ&amp;Symbol=GH"/>
      </figure>
    </article>
  </body>
</html>